
Ergomed Investor Relations Material
Latest events

H2 2022
Ergomed
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ergomed plc
Access all reports
Ergomed plc, operates as a clinical research service provider for pharmaceutical and biotechnology companies internationally. The company offers services at all stages of the clinical development process, from study feasibility to final data analysis and reporting. It also provides various resources and services that support the conduct of clinical trials, including patient recruitment, monitoring support, data management, training services, analytical laboratory studies in toxicology, pharmacokinetics/pharmacodynamics (PK/PD), clinical trial material manufacturing (CTM), pharmacovigilance and medical information services. In addition, the company provides certain services to the non-interventional post-marketing phase of drug development; and in support of over-the-counter (OTC) products.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
ERGO
Country
🇬🇧 United Kingdom